Cetuximab Extravasation
Open Access
- 1 March 2013
- journal article
- case report
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 43 (1), 49-50
- https://doi.org/10.1002/j.2055-2335.2013.tb00216.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialThe Lancet Oncology, 2012
- Extravasation of Cytotoxic AgentsPublished by Springer Science and Business Media LLC ,2010
- Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study GroupJournal of Clinical Oncology, 2009
- Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemiaHaematologica, 2009
- Extravasation of systemic hemato-oncological therapiesAnnals of Oncology, 2004